GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (ASX:MEM) » Definitions » Institutional Ownership

Memphasys (ASX:MEM) Institutional Ownership : 0.00% (As of May. 04, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Memphasys Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Memphasys's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Memphasys's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Memphasys's Float Percentage Of Total Shares Outstanding is 0.00%.


Memphasys Institutional Ownership Historical Data

The historical data trend for Memphasys's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Memphasys Institutional Ownership Chart

Memphasys Historical Data

The historical data trend for Memphasys can be seen below:

2009-01-31 2009-02-28 2009-03-31 2009-04-30 2009-05-31 2009-06-30 2009-07-31 2009-08-31 2009-09-30 2009-10-31
Institutional Ownership 4.74 4.52 0.41 0.41 0.24 0.23 0.23 0.23 0.03 0.03

Memphasys Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Memphasys (ASX:MEM) Business Description

Traded in Other Exchanges
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys (ASX:MEM) Headlines

No Headlines